RxDoctor Payments Data

Megan Larson, NP

Nurse Practitioner · Boise, IDNPI 1861935660

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 67.6% of it on its own, with 7 other manufacturers making up the rest. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,023in general payments, 2019–2025

Across 144 payments — averaging $34.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$892
  • Impulse Dynamics (USA) Inc.$273
  • Biosense Webster, Inc.$249
  • Medtronic$120
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$54
  • plus $41 from 2 others

What the payments were for

  • Food & beverage$5,023100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,023 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$24,535
Medicare patients
309
Services billed
336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban812$1,099,353
XareltoRivaroxaban130$155,454
MultaqDronedarone Hcl27$38,413
Flecainide Acetate173$7,749
SotalolSotalol Hcl285$7,250
Diltiazem 24hr Er (Cd)Diltiazem Hcl158$6,768
Amiodarone Hcl206$6,253
Metoprolol Succinate359$5,137
Mexiletine Hcl24$3,021
Dabigatran EtexilateDabigatran Etexilate Mesylate14$2,720
Digoxin64$1,404
Cartia XtDiltiazem Hcl42$1,377
Verapamil ErVerapamil Hcl27$943
Carvedilol53$866
Metoprolol Tartrate98$844

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →